{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:27:20Z","timestamp":1760189240734},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.jacl.2012.01.004","type":"journal-article","created":{"date-parts":[[2012,1,21]],"date-time":"2012-01-21T20:05:36Z","timestamp":1327176336000},"page":"368-373","source":"Crossref","is-referenced-by-count":16,"title":["Lipoprotein(a) particle concentration and lipoprotein(a) cholesterol assays yield discordant classification of patients into four physiologically discrete groups"],"prefix":"10.1016","volume":"6","author":[{"given":"Matthew","family":"Konerman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnaji","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter P.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2012.01.004_bib1","series-title":"The Johns Hopkins Textbook of Dyslipidemia","first-page":"222","article-title":"Lipoprotein(a): a pleotropic risk factor for cardiovascular disease","author":"Schaefer","year":"2010"},{"key":"10.1016\/j.jacl.2012.01.004_bib2","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2012.01.004_bib3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0002-9149(91)90862-F","article-title":"Prevalence of lipoprotein(a) [Lp(a)] excess in coronary artery disease","volume":"67","author":"Genest","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2012.01.004_bib4","series-title":"Clinical Lipidology: a Companion to Braunwald\u2019s Heart Disease","first-page":"130","article-title":"Lipoprotein(a)","author":"Koschinsky","year":"2009"},{"key":"10.1016\/j.jacl.2012.01.004_bib5","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.CIR.100.11.1154","article-title":"Role of lipoprotein (a) and apolipoprotein(a) phenotype in atherogenesis. Prospective results from the Bruneck study","volume":"100","author":"Kronenberg","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2012.01.004_bib6","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/ATVBAHA.107.145805","article-title":"Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phopholipase A2 activity, and 10-year cardiovascular outcome. Prospective results from the Bruneck study","volume":"27","author":"Kiechl","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2012.01.004_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","article-title":"Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease","volume":"353","author":"Tsimikas","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2012.01.004_bib8","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2012.01.004_bib9","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/01.ATV.20.12.2619","article-title":"High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African-American and White men","volume":"20","author":"Paultre","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2012.01.004_bib10","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.0000280571.28102.d4","article-title":"New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease","volume":"27","author":"Tsimikas","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2012.01.004_bib11","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/clinchem\/45.7.1039","article-title":"Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study","volume":"45","author":"Seman","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2012.01.004_bib12","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1373\/clinchem.2003.030031","article-title":"Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: the physicians\u2019 health study","volume":"50","author":"Rifai","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2012.01.004_bib13","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1093\/clinchem\/46.12.1956","article-title":"Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a)","volume":"46","author":"Marcovina","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2012.01.004_bib14","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1373\/clinchem.2003.023689","article-title":"Report of the National Heart, Lung, and Blood Institute workshop on lipoprotein(a) and cardiovascular disease: recent advances and future directions","volume":"49","author":"Marcovina","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2012.01.004_bib15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1515\/CCLM.2004.114","article-title":"First WHO\/IFCC international reference reagent for lipoprotein(a) for immunoassay\u2013Lp(a) SRM 2B","volume":"42","author":"Dati","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jacl.2012.01.004_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-2275(20)40123-3","article-title":"Quantification of cholesterol in all lipoprotein classes by the VAP-II method","volume":"35","author":"Kulkarni","year":"1994","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2012.01.004_bib17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy","volume":"26","author":"Jeyarajah","year":"2006","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.jacl.2012.01.004_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2012.01.004_bib19","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/S0022-2275(20)31535-2","article-title":"Isolation, quantitation, and characterization of a stable complex formed by Lp(a) binding to triglyceride-rich lipoproteins","volume":"42","author":"Gaubatz","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2012.01.004_bib20","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1172\/JCI112345","article-title":"Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein(a) and that cause lipid accumulation in macrophages","volume":"77","author":"Bersot","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2012.01.004_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0021-9150(93)90117-D","article-title":"Plasma triglycerides and lipoprotein(a): inverse relationship in a hyperlipidemic Italian population","volume":"101","author":"Werba","year":"1993","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2012.01.004_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0009-3084(94)90129-5","article-title":"Triglyceride-rich lipoprotein interactions with Lp(a)","volume":"67","author":"McConathy","year":"1994","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.jacl.2012.01.004_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0021-9150(91)90244-W","article-title":"Plasma lipoprotein distribution of apolipoprotein(a) in the fed and fasted states","volume":"90","author":"Cohn","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2012.01.004_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0021-9150(94)90109-0","article-title":"Decreased plasma levels of lipoprotein(a) in patients with hypertriglyceridemia","volume":"108","author":"Bartens","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2012.01.004_bib25","doi-asserted-by":"crossref","first-page":"17793","DOI":"10.1074\/jbc.273.28.17793","article-title":"Apolipoprotein(a) synthesis and secretion from hepatoma cells is coupled to triglyceride synthesis and secretion","volume":"273","author":"Nassir","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2012.01.004_bib26","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1172\/JCI119753","article-title":"The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor","volume":"100","author":"Argraves","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2012.01.004_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2174\/1567270000805010019","article-title":"Viewing the cardiovascular pathogenicity of Lp(a) from the pro-inflammatory side","volume":"5","author":"Philips","year":"2008","journal-title":"Vasc Dis Prev"},{"key":"10.1016\/j.jacl.2012.01.004_bib28","doi-asserted-by":"crossref","first-page":"52841","DOI":"10.1074\/jbc.M310425200","article-title":"Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a)","volume":"278","author":"Edelstein","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2012.01.004_bib29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MOL.0b013e328308b622","article-title":"The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity","volume":"19","author":"Tsimikas","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2012.01.004_bib30","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1194\/jlr.M012526","article-title":"Lipoprotein(a) levels, apolipoprotein(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study","volume":"52","author":"Lamon-Fava","year":"2011","journal-title":"J Lipid Res"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287412000189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287412000189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,26]],"date-time":"2021-12-26T18:23:39Z","timestamp":1640543019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287412000189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1933287412000189"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2012.01.004","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}